Reliability and Usefulness of ChatGPT for Inflammatory Bowel Diseases: An Analysis for Patients and Healthcare Professionals

被引:14
|
作者
Cankurtaran, Rasim Eren [1 ]
Polat, Yunus Halil [2 ]
Aydemir, Neslihan Gunes [3 ]
Umay, Ebru [4 ]
Yurekli, Oyku Tayfur [5 ]
机构
[1] Ankara Etlik City Hosp, Dept Perinatol, Ankara, Turkiye
[2] Ankara Numune Training & Res Hosp, Dept Gastroenterol, Ankara, Turkiye
[3] Akdeniz Univ, Fac Med, Dept Gastroenterol, Antalya, Turkiye
[4] Univ Hlth Sci, Ankara Etlik City Hosp, Phys Med & Rehabil, Ankara, Turkiye
[5] Ankara Yildirim Beyazit Univ, Fac Med, Dept Gastroenterol, Ankara, Turkiye
关键词
ulcerative colitis (uc); crohn's disease (cd); healthcare research; artificial intelligence (ai); inflammatory; bowel diseases (ibd); large language model; chatgpt;
D O I
10.7759/cureus.46736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: We aimed to evaluate the performance of Chat Generative Pre-trained Transformer (ChatGPT) within the context of inflammatory bowel disease (IBD), which is expected to become an increasingly significant health issue in the future. In addition, the objective of the study was to assess whether ChatGPT serves as a reliable and useful resource for both patients and healthcare professionals.Methods: For this study, 20 specific questions were identified for the two main components of IBD, which are Crohn's disease (CD) and ulcerative colitis (UC). The questions were divided into two sets: one set contained questions directed at healthcare professionals while the second set contained questions directed toward patients. The responses were evaluated with seven-point Likert-type reliability and usefulness scales.Results: The distribution of the reliability and utility scores was calculated into four groups (two diseases and two question sources) by averaging the mean scores from both raters. The highest scores in both reliability and usefulness were obtained from professional sources (5.00 +/- 1.21 and 5.15 +/- 1.08, respectively). The ranking in terms of reliability and usefulness, respectively, was as follows: CD questions (4.70 +/- 1.26 and 4.75 +/- 1.06) and UC questions (4.40 +/- 1.21 and 4.55 +/- 1.31). The reliability scores of the answers for the professionals were significantly higher than those for the patients (both raters, p=0.032).Conclusion: Despite its capacity for reliability and usefulness in the context of IBD, ChatGPT still has some limitations and deficiencies. The correction of ChatGPT's deficiencies and its enhancement by developers with more detailed and up-to-date information could make it a significant source of information for both patients and medical professionals.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases
    Aomatsu, T.
    Inoue, K.
    Yoden, A.
    Okuhira, T.
    Emiri, K.
    Tamai, H.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S408 - S408
  • [22] IBD AND QUALITY OF CARE: HEALTHCARE QUALITY DEFINITION AND MEASURE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Cortelezzi, C. C.
    Rusconi, F.
    Lucci, D. I.
    Parravicini, M.
    Segato, S.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E234 - E234
  • [23] MACHINE LEARNING PREDICTION OF LONGITUDINAL HEALTHCARE UTILIZATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES
    Limketkai, Berkeley N.
    Maas, Laura A.
    Krishna, Mahesh
    Dua, Anoushka
    DeDecker, Lauren C.
    Xu, Helen Y.
    Sauk, Jenny S.
    Parian, Alyssa
    GASTROENTEROLOGY, 2022, 162 (07) : S410 - S410
  • [24] Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases
    Inoue, Keisuke
    Aomatsu, Tomoki
    Yoden, Atsushi
    Okuhira, Takeru
    Kaji, Emiri
    Tamai, Hiroshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (07) : 1406 - 1412
  • [25] Vaccination in Patients with Inflammatory Bowel Diseases
    Manser, Christine N.
    Maillard, Michel H.
    Rogler, Gerhard
    Schreiner, Philipp
    Rieder, Florian
    Buehler, Silja
    DIGESTION, 2020, 101 (SUPPL 1) : 58 - 68
  • [26] Inflammatory bowel diseases in COPD patients
    Berdyugina, Antonina
    Klester, Elena
    Klester, Karolina
    Elykomov, Valery
    Belova, Irina
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [27] Leukocytapheresis in patients with inflammatory bowel diseases
    Wozniak, Malgorzata
    Kurnatowska, Ilona
    Malecka-Panas, Ewa
    Talar-Wojnarowska, Renata
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2021, 16 (02): : 99 - 105
  • [28] Enthesopathies in patients with inflammatory bowel diseases
    Gainullina, G.
    Abdulganieva, D.
    Kirillova, E.
    Odintsova, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I266 - I267
  • [29] Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
    Markiewicz-Loskot, Grazyna
    Chlebowczyk, Wojciech
    Holecki, Tomasz
    CHILDREN-BASEL, 2023, 10 (07):
  • [30] Patient-reported healthcare expectations in inflammatory bowel diseases
    Pittet, Valerie
    Vaucher, Carla
    Froehlich, Florian
    Maillard, Michel H.
    Michetti, Pierre
    PLOS ONE, 2018, 13 (05):